vimarsana.com

Page 6 - Research In Multiple Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST

Updated Interim Results for the Six Months Ended 30 June 2023 NEW YORK, December 29, 2023 - Tiziana Life Sciences, Ltd. , a biotechnology company developing breakthrough.

United statesUnited kingdomCity ofTanuja chitnisMatthew davisMonte carloGabriele cerroneSaef izzyWilliama haseltineWilliama clementiPaul spencerIrina kofflerHoward weinerTiziana life sciencesLifesci advisorsPharma ltd

Tiziana Life Sciences : Interim Results for the Six Months Ended 30 June 2023 863 7 KB -December 29, 2023 at 04:39 pm EST

Tiziana Life Sciences Ltd Updated Interim Results for the Six Months Ended 30 June 2023 NEW YORK, December 29, 2023 -.

United statesGabriele cerroneTanuja chitnisMatthew davisIrina kofflerHoward weinerSaef izzyWilliama haseltinePaul spencerWilliama clementiTiziana life sciencesLifesci advisorsInternational conference on alzheimerInvestment in related partyTiziana life sciences ltdBusiness development

USA Health multiple sclerosis specialist presents findings at world conference

William Kilgo, M.D., a neurologist with USA Health, recently shared research findings using a first-of-its-kind blood test that monitors multiple sclerosis (MS) disease activity in a poster …

United statesWilliam kilgoAmericas committee for treatmentResearch in multiple sclerosisUnited states healthOctave bioscience incEuropean committee for treatmentFrederickp whiddon college of medicineMultiple sclerosis disease activityEuropean committeeMultiple sclerosisAmericas committee

New Data on CD40 Ligand Inhibitor for Relapsing MS

Novel agent led to sustained reduction of new lesions at 24 weeks

Gabrielle macaronPatrick vermerschGreg laubEuropean committee for treatmentAmericas committee for treatmentResearch in multiple sclerosisEuropean committeeMultiple sclerosisAmericas committeeMedpage todaySenior director

What Does It Really Mean to Cure Multiple Sclerosis?

A keynote address at the ECTRIMS 2023 conference sparks hope that a cure for MS is within reach.

City ofUnited kingdomUnited statesSan franciscoStephen hauserJohn richertEuropean committee for treatmentNational ms societyResearch in multiple sclerosisUniversity of californiaEuropean committeeMultiple sclerosisMedpage todayCure lookLife with multiple sclerosisCurrent goal

vimarsana © 2020. All Rights Reserved.